NCI-H295R In Vitro RNA Expression Analysis Assay (DNA Microarray)

CAT#: ITS-1022-YF2712
Target Cell Organism: Human
Target Cell Alternative Name: H295R
Target Cell Name: NCI-H295R
Assay Type: Gene and Protein Expression Assays
Assay Overview
This assay is to provide NCI-H295R-based In Vitro RNA Expression Analysis Assay (DNA Microarray) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NCI-H295R
Target Cell Organism
Human
Target Cell Background
NCI-H295R [H295R] are cells that were isolated from the adrenal gland of a 48-year-old, Black, female adrenal cancer patient. This cell line has the ability to produce adrenal androgens.
Target Cell Alternative Name
H295R
Related Diseases
Adrenal Cancer
Research Area
Oncology
Assay Name
In Vitro RNA Expression Analysis Assay (DNA Microarray)
Short Description
NCI-H295R-cell based In Vitro RNA Expression Analysis Assay (DNA Microarray)
Assay Description
DNA microarray is another technique that enables the analysis of gene expression. Fluorescent labeled cDNA (with cyanines) synthesized from a test sample is hybridized to target probes with complementary sequences attached on microarray chips and strongly bound complexes are screened after scanning optically.
Assay Type
Gene and Protein Expression Assays
Assay Type Details
Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.
For Research Use Only | Not For Clinical Use
Online Inquiry